Bortezomib Enhances the Antitumor Effects of Interferon-β Gene Transfer on Melanoma Cells

Autor: Liliana Maria Elena Finocchiaro, Úrsula A. Rossi, Gerardo C. Glikin
Rok vydání: 2016
Předmět:
0301 basic medicine
Cancer Research
Canine
Bortezomib
chemistry.chemical_compound
0302 clinical medicine
Cell Movement
Tumor Cells
Cultured

Interferon-Β
Cytotoxic T cell
Melanoma
Lipofection
Molecular Structure
Cell Cycle
Ros
Bioquímica y Biología Molecular
Cell cycle
Medicina Básica
030220 oncology & carcinogenesis
Molecular Medicine
DNA fragmentation
CIENCIAS NATURALES Y EXACTAS
Human
medicine.drug
CIENCIAS MÉDICAS Y DE LA SALUD
Cell Survival
Antineoplastic Agents
Biology
Ciencias Biológicas
03 medical and health sciences
Structure-Activity Relationship
Biología Celular
Microbiología

medicine
Humans
Propidium iodide
Viability assay
Cell Proliferation
Pharmacology
Dose-Response Relationship
Drug

Ciencias Veterinarias
Genetic Therapy
Interferon-beta
medicine.disease
Molecular biology
030104 developmental biology
chemistry
CIENCIAS AGRÍCOLAS
Apoptosis
Liposomes
Cancer research
Spheroids
Drug Screening Assays
Antitumor

Reactive Oxygen Species
Zdroj: Anti-cancer agents in medicinal chemistry. 17(5)
ISSN: 1875-5992
Popis: We evaluated the cytotoxic effects of the combination of bortezomib (BTZ) and interferon-β (IFNβ) gene lipofection on cultured melanoma cells. Four canine mucosal (Ak, Br, Bk and Ol) and two human dermal (A375 and SB2) melanoma cell lines were assayed. BTZ sub-pharmacological concentrations (5 nM) enhanced the cytotoxic effects of IFNβ transgene expression on melanoma cells monolayers and spheroids. The combination was also more effective than the single treatments when assayed for clonogenic survival and cell migration. The combined treatment produced a significant raise of apoptosis evidenced by DNA fragmentation as compared to either BTZ or IFNβ gene lipofection single treatments. Furthermore, BTZ significantly increased the intracellular reactive oxygen species (ROS) generation induced by IFNβ gene transfer in melanoma cells, an effect that was reversed by the addition of the ROS inhibitor N-acetyl-L-cystein. The present work encourages further studies about the potential of the combination of interferon gene transfer with proteasome inhibitors as a new combined therapy for malignant melanoma, both in veterinary and/or human clinical settings. Fil: Rossi, Ursula Amaranta. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina Fil: Finocchiaro, Liliana Maria Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina Fil: Glikin, Gerardo Claudio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
Databáze: OpenAIRE